Steatocrit Test · Stool

If you are losing weight you did not intend to lose, passing pale or oily stools that float, or feeling drained no matter how well you eat, the problem may not be what reaches your plate. It may be what never reaches your bloodstream. Steatocrit gives you a direct readout of whether the fat in your food is being absorbed or escaping in stool.

Most people only learn they have fat malabsorption after months of symptoms have already eroded their weight, energy, and fat-soluble vitamin stores. This simple stool test offers an earlier window into the digestive machinery that turns food into fuel.

What Steatocrit Actually Measures

The lab takes a stool sample, spins it down in a tube, and reports the height of the fat layer as a percentage of the total column. The higher the percentage, the more fat is leaving your body unabsorbed. Three variants of the test exist: the classical method, the acid steatocrit (where the sample is acidified first to improve fat separation), and a post-fatty-meal version.

The acid version is the most validated. In adults, it caught about 100 out of 100 cases of true fat malabsorption while correctly clearing 95 out of 100 people without it, with a moderate-to-strong link to the gold-standard 72-hour fecal fat collection (correlation around 0.76, where 1.0 would be a perfect match). Other research in adults reported it caught about 87 out of 100 cases and correctly cleared 97 out of 100 healthy people.

Chronic Pancreatitis

Your pancreas releases the enzymes that break fat into pieces small enough to absorb. When chronic inflammation damages the pancreas, fat starts slipping past your gut. The hard part is that you usually feel fine until the damage is far along.

In one study of adults with chronic pancreatitis, relying on symptoms alone (greasy stools, weight loss) caught only 38 out of 100 cases of actual fat malabsorption. Most patients developed exocrine dysfunction within 5 to 10 years of diagnosis, and undetected fat losses were a major contributor to their weight loss. The authors recommended that everyone with chronic pancreatitis be screened early with acid steatocrit, regardless of cause.

Cystic Fibrosis

In cystic fibrosis (a genetic condition that thickens secretions and damages the pancreas), steatocrit has been used for decades to track fat absorption and adjust pancreatic enzyme doses. In one large pediatric series, steatocrit moved closely with directly measured fat excretion (a strong correlation of 0.93).

The picture is not perfect, though. In adults with cystic fibrosis whose steatorrhea was already mild or controlled, steatocrit became unreliable, and a separate study in 27 people with cystic fibrosis found it imprecise compared to direct fat-absorption measurement. The takeaway: steatocrit is most useful when there is meaningful fat loss to detect, and least useful when the picture is already nearly normal.

Celiac Disease and Intestinal Damage

Even when the pancreas is working, fat absorption can fail if the lining of the small intestine is damaged. Celiac disease, the autoimmune reaction to gluten, can flatten the absorbing surface (a process called villous atrophy) and let fat slip through. In a study of 116 people, a steatocrit measured after a standardized fatty meal correctly identified everyone with biopsy-confirmed villous atrophy, with no false positives or false negatives.

Reference Ranges

Steatocrit values vary meaningfully by age. Infants normally lose more fat in stool than older children or adults, and breast-fed and formula-fed babies differ. Some adult labs use a cutoff around 10 to 15 percent to flag steatorrhea, but no single number is universally accepted, and the assay is not standardized across labs. The ranges below are drawn from published studies and should be treated as orientation, not as universal targets. Your lab will likely report different numbers.

Compare your results within the same lab over time for the most meaningful trend. Cross-lab comparisons are unreliable because methods differ.

When Results Can Be Misleading

Steatocrit is sensitive to several factors that can shift the number without reflecting true digestive failure.

• Recent dietary fat: a single very fatty meal in the days before sampling can transiently inflate the result. A consistent, moderate-fat diet during sample collection gives the most reliable reading.
• Lab-to-lab variability: the test is technically simple, but results vary by method (classical vs acid) and by operator. One study in cystic fibrosis labeled the classical version unreliable for clinical use.
• Mild or treated disease: in people whose fat loss is already small, steatocrit loses precision and can read normal even when subtle malabsorption is present.
• Stool consistency and timing: very watery diarrhea can dilute the sample, while delayed processing changes how fat layers separate.

Tracking Your Trend

A single steatocrit reading is a snapshot. Fat losses fluctuate with what you eat, how much enzyme support you have, and how active your underlying condition is on a given day. The number that matters is the trend over time, especially when you are starting or adjusting a treatment like enzyme replacement.

If you are investigating unexplained symptoms, get a baseline. If you are starting pancreatic enzymes, retest in 4 to 8 weeks to see whether the dose is working. After that, retest at least annually if you have a chronic condition that affects fat absorption, or sooner if symptoms change.

What to Do With an Abnormal Result

An elevated steatocrit tells you fat is being lost, but it does not tell you why. The next step is to figure out which part of the digestive system is failing. The two main suspects are the pancreas (not making enough fat-digesting enzymes) and the small intestine (damaged surface that cannot absorb).

Pair an abnormal steatocrit with a fecal elastase-1 test, which specifically reflects pancreatic enzyme output, and with celiac antibody testing if intestinal damage is suspected. A meta-analysis found fecal elastase-1 to be a sensitive screening tool for pancreatic exocrine insufficiency, and one head-to-head study in pancreatitis found it identified more cases than steatocrit alone. If the pattern points to a pancreatic cause, a gastroenterologist can guide enzyme replacement; if it points to intestinal damage, the workup shifts toward celiac disease, inflammatory bowel disease, or related conditions.